Search

everythinglearnresearchcommunity

for

Search:↓

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Animal models are crucial for learning about hair loss and finding treatments.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Finasteride treatment in male rats can reduce fertility and affect sperm development in their offspring.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Ultra-high molecular weight poly-γ-glutamic acid may help promote hair growth.

Hormonal imbalances may play a role in frontal fibrosing alopecia, and antiandrogenic drugs combined with steroids are currently the most effective treatment.

Finasteride effectively treats male hair loss, increasing length and thickness.

Asparagus racemosus root extract reduced sebum and pore size in men but not in women.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Finasteride use during early pregnancy may cause limb deformities in babies.

Finasteride use may be linked to rare testicular tumor, but more research needed.

Citrullus colocynthis fruit extract and its compound may help treat enlarged prostate.

Garden cress extract may help treat skin inflammation and androgen-related disorders.